Advertisement

Reactions Weekly

, Volume 1777, Issue 1, pp 55–55 | Cite as

Brentuximab vedotin

Neutropenia and anaemia: 2 case reports
Case report
  • 13 Downloads

Reference

  1. Tien F-M, et al. Brentuximab vedotin as a salvage treatment for relapsed and refractory Hodgkin lymphoma patients in Taiwan. Journal of the Formosan Medical Association 118: 1466-1470, No. 10, Oct 2019. Available from: URL: http://doi.org/10.1016/j.jfma.2019.07.003 - Taiwan

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations